ImmunityBio, Inc. (IBRX)
7.575
-0.22
(-2.76%)
USD |
NASDAQ |
Aug 24, 16:00
7.52
-0.06
(-0.73%)
After-Hours: 20:00
ImmunityBio Total Assets (Quarterly) : 628.50M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 628.50M |
| March 31, 2026 | 646.64M |
| December 31, 2025 | 501.90M |
| September 30, 2025 | 518.99M |
| June 30, 2025 | 402.08M |
| March 31, 2025 | 303.76M |
| December 31, 2024 | 382.93M |
| September 30, 2024 | 364.57M |
| June 30, 2024 | 444.32M |
| March 31, 2024 | 400.68M |
| December 31, 2023 | 504.45M |
| September 30, 2023 | 432.42M |
| June 30, 2023 | 291.23M |
| March 31, 2023 | 343.40M |
| December 31, 2022 | 362.36M |
| September 30, 2022 | 352.94M |
| June 30, 2022 | 317.72M |
| March 31, 2022 | 389.59M |
| December 31, 2021 | 468.91M |
| September 30, 2021 | 214.42M |
| June 30, 2021 | 246.30M |
| March 31, 2021 | 209.43M |
| December 31, 2020 | 151.86M |
| September 30, 2020 | 180.54M |
| Date | Value |
|---|---|
| June 30, 2020 | 196.16M |
| March 31, 2020 | 127.02M |
| December 31, 2019 | 143.12M |
| September 30, 2019 | 160.21M |
| June 30, 2019 | 175.70M |
| March 31, 2019 | 208.26M |
| December 31, 2018 | 181.95M |
| September 30, 2018 | 201.64M |
| June 30, 2018 | 211.43M |
| March 31, 2018 | 229.84M |
| December 31, 2017 | 250.44M |
| September 30, 2017 | 277.74M |
| June 30, 2017 | 301.62M |
| March 31, 2017 | 303.68M |
| December 31, 2016 | 317.50M |
| September 30, 2016 | 332.41M |
| June 30, 2016 | 342.94M |
| March 31, 2016 | 357.43M |
| December 31, 2015 | 366.85M |
| September 30, 2015 | 370.19M |
| June 30, 2015 | 132.56M |
| March 31, 2015 | 52.14M |
| December 31, 2014 | 60.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 3.189B |
| Cogent Biosciences, Inc. | 834.55M |
| Moderna, Inc. | 10.96B |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.674B |
| Shareholders Equity (Quarterly) | -1.047B |
| Debt to Equity Ratio | -1.174 |
| Current Ratio | 5.721 |
| Net Debt Paydown Yield | -0.88% |